J.P. Morgan South Africa Healthcare Seminar

Feb 14, 2022

March 15, 2022
1:00 am to 7:00 am PDT (10:00 to 16:00 SAST)
Dr. Soon-Shiong will be providing an overview of NantWorks, including ImmunityBio, and discuss the healthcare challenges affecting African countries.
Note: J.P. Morgan’s South Africa Healthcare Seminar is for J.P. Morgan clients and not open to the public.
Registration link

Contact us at

844-696-5235

How Can ImmunityBio Help You?

Solutions for Patients

Many therapies for treating cancer and infectious disease severely weaken the immune system—the human body’s most important natural disease-fighting weapon. But ImmunityBio creates targeted, personalized immunotherapies that are designed to strengthen the immune system and enable it to outsmart your disease.

Opportunities for Trial Investigators

Immunotherapies and cell therapies are key to future cancer treatments. Our investigational IL-15 superagonist, N-803, and NK-92®-engineered cells have demonstrated wide therapeutic potential across multiple tumor types, and, in clinical studies, have proven to be well-tolerated, making them ideal for clinical trial investigations.

Solutions for Research Scientists

Our NK-92® cell line provides a versatile bioanalytical testing solution that helps researchers develop functional killing assays that are more consistent and reliable than donor blood and reporter gene assays.

ImmunityBio is continuously pursuing new immunotherapies designed to attack disease by enhancing the patient’s immune system, not weakening it.